<DOC>
	<DOCNO>NCT00785356</DOCNO>
	<brief_summary>Subjects randomly assign one 3 treatment group receive 325 mg ( 65 mg elemental iron ) iron supplement twice daily .</brief_summary>
	<brief_title>Safety Efficacy Proellex Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids</brief_title>
	<detailed_description>Eligible female subject randomly assign one three treatment group . Subjects receive 325 mg ( 65 mg elemental iron ) iron supplement take twice daily study drug treatment . The study duration approximately six month , comprise 4 - 6 week screening period , three-month drug treatment period , one-month follow-up period .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Female , age 18 48 year Body Mass Index ( BMI ) 18 39 , inclusive ; Anemic , define hemoglobin level less equal 10.5 g/dL uterine fibroidassociated symptom indicate history excessive menstrual bleeding ; Surgical intervention uterine fibroid ( e.g . hysterectomy myomectomy ) plan anticipate study ; Willing comply study procedure , include endometrial biopsy blood draws visit , include Followup Visits Postmenopausal woman woman likely become postmenopausal study , define one following : Six month ( immediately prior Screening Visit ) without menstrual period , Prior hysterectomy , Prior bilateral oophorectomy ( unilateral oophorectomy exclusionary regular menstruation occur ) ; Females undergone uterine arterial embolization , endometrial ablation therapy ( previous myomectomy acceptable ) cause ; Documented endometriosis active pelvic inflammatory disease ( PID ) ; Having diagnosis , suspect diagnosis , carcinoma breast reproductive organ ; Known active infection HIV , Hepatitis A , B C , Gonorrhea , Chlamydia ; Use prohibit concomitant medication : 1 . DepoProvera use must cease ten month prior first dose study drug , 2 . GnRH agonists use ( e.g . Lupron Depot ) must cease six month prior first dose study drug , 3 . Oral contraceptive hormonal treatment use must cease 30 day prior start study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Uterine fibroid</keyword>
	<keyword>Anemia</keyword>
</DOC>